Imaging mass spectrometry for improved prostate cancer...

Details Imaging mass spectrometry for improved prostate cancer... Imaging mass spectrometry for improved prostate cancer...

G - Physics

01

N

G01N 27/00 (2006.01) G01N 27/62 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2714956

The invention provides biomarkers that can discriminate between prostate cancer and normal tissue as well as identification of associated metastatic disease. One biomarker was identified as a peptide fragment of MEKK2. Methods of diagnosing prostate cancer, including metastatic cancer, by detecting the differential expression of one or more biomarkers are also provided.

L'invention concerne des marqueurs biologiques capables de discriminer le cancer de la prostate d'un tissu normal, ainsi que l'identification d'une maladie métastasique associée. Un marqueur biologique a été identifié comme un fragment peptidique de MEKK2. L'invention concerne également des procédés de diagnostic du cancer de la prostate, notamment un cancer métastasique, par détection de l'expression différentielle d'un ou plusieurs marqueurs biologiques.

Affiliated with

Also associated with

Rating

Imaging mass spectrometry for improved prostate cancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imaging mass spectrometry for improved prostate cancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imaging mass spectrometry for improved prostate cancer... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1519379